Delaware House Bill 364

---

Spectrum: Strong Partisan Bill (Democrat 10-1)
Status: Introduced on April 11 2024 - 25% progression
Action: 2024-04-16 - Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits
Text: Latest bill text (Draft #1) [HTML]

This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.

An Act To Amend Title 18 Of The Delaware Code Relating To Cancer Coverage.

Rep. Cyndie Romer [D]	Sen. Nicole Poore [D]	Sen. Kyra Hoffner [D]	Sen. David Sokola [D]
Rep. Paul Baumbach [D]	Rep. William Carson [D]	Rep. Timothy Dukes [R]	Rep. Debra Heffernan [D]
Rep. Larry Lambert [D]	Rep. Eric Morrison [D]	Rep. Madinah Wilson-Anton [D]

Date	Chamber	Action
2024-04-16		Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits
2024-04-11		Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House

Type	Source
Summary	https://legis.delaware.gov/BillDetail?LegislationId=141172
Text	https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=141172&legislationTypeId=1&docTypeId=2&legislationName=HB364